pyrazole has been researched along with Alloxan Diabetes in 5 studies
1H-pyrazole : The 1H-tautomer of pyrazole.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hernández-Vázquez, E | 1 |
| Ocampo-Montalban, H | 1 |
| Cerón-Romero, L | 1 |
| Cruz, M | 1 |
| Gómez-Zamudio, J | 1 |
| Hiriart-Valencia, G | 1 |
| Villalobos-Molina, R | 1 |
| Flores-Flores, A | 1 |
| Estrada-Soto, S | 1 |
| Naim, MJ | 1 |
| Alam, O | 1 |
| Alam, MJ | 1 |
| Shaquiquzzaman, M | 1 |
| Alam, MM | 1 |
| Naidu, VGM | 1 |
| López-Viseras, ME | 1 |
| Fernández, B | 1 |
| Hilfiker, S | 1 |
| González, CS | 1 |
| González, JL | 1 |
| Calahorro, AJ | 1 |
| Colacio, E | 1 |
| Rodríguez-Diéguez, A | 1 |
| Sagar, SR | 1 |
| Agarwal, JK | 1 |
| Pandya, DH | 1 |
| Dash, RP | 1 |
| Nivsarkar, M | 1 |
| Vasu, KK | 1 |
| Rikimaru, K | 1 |
| Wakabayashi, T | 1 |
| Abe, H | 1 |
| Imoto, H | 1 |
| Maekawa, T | 1 |
| Ujikawa, O | 1 |
| Murase, K | 1 |
| Matsuo, T | 1 |
| Matsumoto, M | 1 |
| Nomura, C | 1 |
| Tsuge, H | 1 |
| Arimura, N | 1 |
| Kawakami, K | 1 |
| Sakamoto, J | 1 |
| Funami, M | 1 |
| Mol, CD | 1 |
| Snell, GP | 1 |
| Bragstad, KA | 1 |
| Sang, BC | 1 |
| Dougan, DR | 1 |
| Tanaka, T | 1 |
| Katayama, N | 1 |
| Horiguchi, Y | 1 |
| Momose, Y | 1 |
5 other studies available for pyrazole and Alloxan Diabetes
| Article | Year |
|---|---|
Antidiabetic, antidyslipidemic and toxicity profile of ENV-2: A potent pyrazole derivative against diabetes and related diseases.
Topics: Adipose Tissue; Animals; Body Weight; Diabetes Mellitus, Experimental; Gene Expression Regulation; G | 2017 |
Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-γ modulators.
Topics: 3T3-L1 Cells; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Dose-Response Relationship, | 2018 |
In vivo potential antidiabetic activity of a novel zinc coordination compound based on 3-carboxy-pyrazole.
Topics: Animals; Body Weight; Diabetes Mellitus, Experimental; Eating; Hypoglycemic Agents; Male; Molecular | 2014 |
Design, synthesis and biological evaluation of novel pyrazolo-pyrimidinones as DPP-IV inhibitors in diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dipeptidyl Peptidase 4; Dose-Response Relat | 2015 |
A new class of non-thiazolidinedione, non-carboxylic-acid-based highly selective peroxisome proliferator-activated receptor (PPAR) γ agonists: design and synthesis of benzylpyrazole acylsulfonamides.
Topics: Animals; Binding Sites; Carboxylic Acids; Computer Simulation; Diabetes Mellitus, Experimental; Dise | 2012 |